Get started
Author

Srinivas Gangula

Observed name: Gangula Srinivas
ORCID: 0000-0002-3765-6877
Observed ORCID: 0000-0002-3765-6877
OpenAlex ID: A5022725636
Commercial-Scale Visible Light Trifluoromethylation of 2-Chlorothiophenol Using CF 3 I Gas
2022 · Kaid C. Harper, En-Xuan Zhang, et al. · Organic Process Research & Development · 39
PDF
Substrate Modification Approach to Achieve Efficient Resolution: Didesmethylcitalopram: A Key Intermediate for Escitalopram
2007 · Chandrashekar R. Elati, Naveenkumar Kolla, et al. · Organic Process Research & Development · 26
Investigation of a Kumada Cross Coupling Reaction for Large-Scale Production of (2S, 7R, E)-2-Isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-N,N,8-trimethylnon-4-enamide
2015 · Srinivas Gangula, Uday Kumar Neelam, et al. · Organic Process Research & Development · 20
An efficient synthesis of dexlansoprazole employing asymmetric oxidation strategy
2011 · Manne Naga Raju, Neelam Uday Kumar, et al. · Tetrahedron Letters · 18
An Improved Process for the Production of Lansoprazole: Investigation of Key Parameters That Influence the Water Content in Final API
2009 · Srinivas Gangula, Chandrasekhar R. Elati, et al. · Organic Process Research & Development · 17
An Alternative Approach to Achieve Enantiopure (3S)-4-Benzyl-3- (4-fluorophenyl)morpholin-2-one: A Key Intermediate of Aprepitant, an NK1 Receptor Antagonist
2007 · Naveenkumar Kolla, Chandrashekar R. Elati, et al. · Organic Process Research & Development · 15
A convergent approach to the synthesis of aprepitant: a potent human NK-1 receptor antagonist
2007 · Chandrashekar R. Elati, Naveenkumar Kolla, et al. · Tetrahedron Letters · 14
Application of Continuous Flow Micromixing Reactor Technology for Synthesis of Benzimidazole Drugs
2013 · Gunupati Sharathchandra Reddy, Narra Santosh Reddy, et al. · Organic Process Research & Development · 13
Synthesis, Optimization, and Large-Scale Preparation of the Low-Dose Central Nervous System-Penetrant BACE1 Inhibitor LY3202626 via a [3 + 2] Nitrone Cycloaddition
2020 · Pablo Garcia-Losada, Amy C. DeBaillie, et al. · Organic Process Research & Development · 12
Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part I: Synthesis of the Pyridazinyl Imidazolidinone Intermediate Enabled by Biocatalysis and CSTR Technologies
2025 · Qiang Yang, Yu Lu, et al. · Organic Process Research & Development · 10
Novel Synthesis of Fosphenytoin: Anti-Convulsant Prodrug
2008 · Chandrashekar R. Elati, Srinivas Gangula, et al. · Synthetic Communications · 10
Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities
2012 · Srinivas Gangula, Naveen Kumar Kolla, et al. · Synthetic Communications · 6
Synthesis of All Enantiomerically Pure Diastereomers of Aprepitant
2010 · Srinivas Gangula, Chandrashekhar R. Elati, et al. · Synthetic Communications · 4
Towards the Development of a Commercial Process To Produce Muvalaplin. Part I: Preparation of a Key Intermediate by an Evans Auxiliary-Assisted Asymmetric Alkylation
2026 · Daniel P. Walker, Matthew J. Genzink, et al. · Organic Process Research & Development · 2
Substrate Modification Approach to Achieve Efficient Resolution: Didesmethylcitalopram: A Key Intermediate for Escitalopram
2007 · Chandrashekar R. Elati, Naveenkumar Kolla, et al. · Organic Process Research & Development · 2
Development of a Scalable Manufacturing Process for Kv1.3 Antagonist LY3972406 Hemiglutarate Hemihydrate
2026 · Xiaoyong Li, Joel R. Calvin, et al. · Organic Process Research & Development · 1
An Improved Process for Repaglinide via an Efficient and One Pot Process of (1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine – A Useful Intermediate
2006 · Naveenkumar Kolla, Chandrashekar R. Elati, et al. · CHIMIA International Journal for Chemistry · 1
PDF
Polymorphic study of donepezil hydrobromide
2005 · Chandrashekar R. Elati, Pravinchandra J. Vankawala, et al. · Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry · 1
Toward the Development of a Commercial Process to Produce Muvalaplin. Part II: Preparation of the Drug Substance
2026 · Daniel P. Walker, John R. Rizzo, et al. · Organic Process Research & Development
A new method for the one-pot synthesis of symmetrical, tertiary benzylic amines via Ir4(CO)12 catalyzed reductive amination of benzaldehydes
2026 · Daniel P. Walker, Matthew J. Genzink, et al. · SSRN Electronic Journal
Scalable synthesis of 3-amino-2, 2-dimethylpropanamide: A key intermediate of Aliskiren
2014 · B. Sudhakar Reddy, Srinivas Gangula, et al.
Structural identification, characterization and synthesis of impurities of Naproxcinod
2014 · Anitha Naredla, Srinivas Gangula, et al.
ChemInform Abstract: Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities.
2013 · Srinivas Gangula, Naveen Kumar Kolla, et al. · ChemInform
Recycling of undesired isomers of key intermediate for aprepitant
2009 · Srinivas Gangula, Chandrashekar R. Elati, et al. · Green Chemistry Letters and Reviews
PDF
ChemInform Abstract: Novel Synthesis of Fosphenytoin: Anticonvulsant Prodrug.
2009 · Chandrashekar R. Elati, Srinivas Gangula, et al. · ChemInform
Works count: 25
Citation count: 211
H-index: 10
I10-index: 11
Year
Topic
Type